Abstract:Introduction Cardiometabolic multimorbidity (CMM) and depression are risk factors for cognitive decline and dementia. We investigated the independent and synergistic associations of CMM and depression on longitudinal cognitive deterioration in two Asian cohorts of elderly at varying cognitive status with differed underlying neuropathology. Methods Eligible memory clinic (Harmonization) and stroke patients (Coast) aged ≥50 completed cognitive and clinical assessments at baseline and up to 5 follow-up visits in 6 years. Cardiometabolic diseases (CMDs), including hypertension, hyperlipidemia, diabetes mellitus, stroke and other cardiovascular diseases were assessed. Presence of CMM was defined as having two or more CMDs. Depression was defined by Geriatric Depression Scale (GDS) of ≥5. Biomarkers including cerebral beta-amyloid, cerebrovascular disease and ApoE genotype, were assessed by MRI and laboratory tests. Cognitive outcomes included cognitive trajectory patterns identified by the group-based trajectory model (GBTM) and the rate of change of global cognitive z-score. Multivariable logistic models and mixed models were conducted to assess the associations of CMM(+) and depression(+) with longitudinal cognitive decline. Stratification analysis by demographics and biomarkers was conducted. Results Among a total of 809 (Harmonization: 586, Coast: 223) participants, three cognitive trajectories were identified by the GBTM in each cohort. CMM(+) was independently associated with longitudinal cognitive decline. There was a significant interaction among CMM, depression and time with longitudinal cognition in both cohorts (ps of β(CMM*depression*time) < 0.05). Compared with reference group, CMM(+) and depression(+) were associated with patterns of rapid decline (OR=3.58, =95%CI=(1.64,7.81)) and slow decline (OR=3.32, 95%CI=(1.20,9.19)) in Harmonization, and decline/low stable (OR=4.01, 95%CI=(1.03,15.50)) in Coast. Participants with CMM(+) and depression(+) had a 0.24 (95%CI= -0.49, -0.01) and 0.13 (95%CI=-0.24,-0.01) units decline per year on global cognitive z-scores in Harmonization and Coast, respectively, compared with those with CMM(-) and depression(-). The combined effect between CMM and depression was more pronounced among older and male participants, as well as APOEε4 carriers. Discussion Our study demonstrated a synergistic effect between CMM and depression on longitudinal cognitive decline among elderly with differed underlying neuropathology. Targeting both CMM and depression in preventing cognitive decline may lead to greater effectiveness.

Depressive symptoms and cognitive decline in older adults

Trajectories of Depressive Symptoms and Subsequent Cognitive Decline in Older Adults: a Pooled Analysis of Two Longitudinal Cohorts

Cognitive trajectories in older adults and the role of depressive symptoms: A 7-year follow-up study

Persistent depressive symptoms and cognitive decline in older adults

Depressive symptoms and cognitive impairment: A 10-year follow-up study from the Survey of Health, Ageing and Retirement in Europe

Trajectories in depressive symptoms and midlife brain health

Depressive Symptoms and Cognitive Function in Older Adults: A Cross‐Lagged Network Analysis

Cognitive Performance Deficits Are Associated with Clinically Significant Depression Symptoms in Older US Adults

Association Between Cognitive Trajectories and Subsequent Health Status, Depressive Symptoms, and Mortality Among Older Adults in the United States: Findings From a Nationally Representative Study

Longitudinal Cognitive Profiles by Anxiety and Depressive Symptoms in American Older Adults with Subjective Cognitive Decline.

Depressive symptoms are linked to age-specific neuroanatomical and cognitive variations

Association between depressive duration and cognitive decline in middle-aged and older adults: Evidence from the Health and Retirement Study 2010–2018

Synergistic Effect of Cardiometabolic Multimorbidity and Depression on Longitudinal Cognitive Decline: Results from Two Longitudinal Asian Elderly Cohorts

Poor mobility and lower limb weakness are associated with three distinct depressive symptom trajectories over 6 years in older people

Late-life Depression and Cognitive Function among Older Adults in the US: the National Health and Nutrition Examination Survey, 2011-2014

Cognitive Trajectories in Community-Dwelling Older Adults and Incident Dementia, Disability and Death: A 10-Year Longitudinal Study

Association of depressive symptoms with decline of cognitive function—Rugao longevity and ageing study

The Trajectory of Depressive Symptoms over Time and the Presence of Depressive Symptoms at a Single Time Point with the Risk of Dementia among US Older Adults: A National Prospective Cohort Study.

Association Between Cognitive Decline and Depression in Middle-Aged and Older Adults: Findings from Six Large Cohorts in Different Countries

Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease